Cargando…
Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causative agent of coronavirus disease 2019 (COVID‐19) and is capable of human‐to‐human transmission and rapid global spread. Thus, the establishment of high‐quality viral detection and quantification methods, and the de...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761427/ https://www.ncbi.nlm.nih.gov/pubmed/34837712 http://dx.doi.org/10.1002/jcla.24146 |
_version_ | 1784633525013577728 |
---|---|
author | Hayashi, Kyoko Asai, Satomi Umezawa, Kazuo Kakizoe, Hidehumi Miyachi, Hayato Morita, Masanobu Akaike, Takaaki Kuno, Hitoshi Komatsu, Satoko Watanabe, Takumi Kawahara, Toshio |
author_facet | Hayashi, Kyoko Asai, Satomi Umezawa, Kazuo Kakizoe, Hidehumi Miyachi, Hayato Morita, Masanobu Akaike, Takaaki Kuno, Hitoshi Komatsu, Satoko Watanabe, Takumi Kawahara, Toshio |
author_sort | Hayashi, Kyoko |
collection | PubMed |
description | BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causative agent of coronavirus disease 2019 (COVID‐19) and is capable of human‐to‐human transmission and rapid global spread. Thus, the establishment of high‐quality viral detection and quantification methods, and the development of anti‐SARS‐CoV‐2 agents are critical. METHODS: Here, we present the rapid detection of infectious SARS‐CoV‐2 particles using a plaque assay with 0.5% agarose‐ME (Medium Electroosmosis) as an overlay medium. RESULTS: The plaques were capable of detecting the virus within 36–40 h post‐infection. In addition, we showed that a monogalactosyl diacylglyceride isolated from a microalga (Coccomyxa sp. KJ) could inactivate the clinical isolates of SARS‐CoV‐2 in a time‐ and concentration‐dependent manner. CONCLUSIONS: These results would allow rapid quantification of the infectious virus titers and help develop more potent virucidal agents against SARS‐CoV‐2. |
format | Online Article Text |
id | pubmed-8761427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87614272022-01-20 Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay Hayashi, Kyoko Asai, Satomi Umezawa, Kazuo Kakizoe, Hidehumi Miyachi, Hayato Morita, Masanobu Akaike, Takaaki Kuno, Hitoshi Komatsu, Satoko Watanabe, Takumi Kawahara, Toshio J Clin Lab Anal Research Articles BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causative agent of coronavirus disease 2019 (COVID‐19) and is capable of human‐to‐human transmission and rapid global spread. Thus, the establishment of high‐quality viral detection and quantification methods, and the development of anti‐SARS‐CoV‐2 agents are critical. METHODS: Here, we present the rapid detection of infectious SARS‐CoV‐2 particles using a plaque assay with 0.5% agarose‐ME (Medium Electroosmosis) as an overlay medium. RESULTS: The plaques were capable of detecting the virus within 36–40 h post‐infection. In addition, we showed that a monogalactosyl diacylglyceride isolated from a microalga (Coccomyxa sp. KJ) could inactivate the clinical isolates of SARS‐CoV‐2 in a time‐ and concentration‐dependent manner. CONCLUSIONS: These results would allow rapid quantification of the infectious virus titers and help develop more potent virucidal agents against SARS‐CoV‐2. John Wiley and Sons Inc. 2021-11-27 /pmc/articles/PMC8761427/ /pubmed/34837712 http://dx.doi.org/10.1002/jcla.24146 Text en © 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Hayashi, Kyoko Asai, Satomi Umezawa, Kazuo Kakizoe, Hidehumi Miyachi, Hayato Morita, Masanobu Akaike, Takaaki Kuno, Hitoshi Komatsu, Satoko Watanabe, Takumi Kawahara, Toshio Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay |
title | Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay |
title_full | Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay |
title_fullStr | Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay |
title_full_unstemmed | Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay |
title_short | Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay |
title_sort | virucidal effect of monogalactosyl diacylglyceride from a green microalga, coccomyxa sp. kj, against clinical isolates of sars‐cov‐2 as assessed by a plaque assay |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761427/ https://www.ncbi.nlm.nih.gov/pubmed/34837712 http://dx.doi.org/10.1002/jcla.24146 |
work_keys_str_mv | AT hayashikyoko virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay AT asaisatomi virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay AT umezawakazuo virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay AT kakizoehidehumi virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay AT miyachihayato virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay AT moritamasanobu virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay AT akaiketakaaki virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay AT kunohitoshi virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay AT komatsusatoko virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay AT watanabetakumi virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay AT kawaharatoshio virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay |